The former Walter Reed Army Medical Center, now known as The Parks at Walter Reed, is adding a new development. A partnership of Hines, Urban Atlantic and Triden Development Group recently closed on a 1.5-acre site for the construction of The Hartley, a 323-unit luxury community. The team has two other communities underway: The Brooks, an 89-unit condominium building, and the 301-unit The Vale. All these projects are set to add much-needed supply to the upper northwest part of Washington, D.C., which has seen limited multifamily construction in the past decades.
Katie Wiacek, managing director with Hines, shared details about the upcoming residential projects and revealed the companys plans within the $1 billion master development. Wiacek expects the live-work-play destination to add a total of more than 2,000 affordable, market-rate and luxury units, as well as senior housing apartments.
READ ALSO: Whos Still Investing in DCs Multifamily Market?
How will The Hartley differ from the other two residential developments that are currently underway at The Parks at Walter Reed?
Wiacek: The Hartley will differentiate from The Vale when it comes to its location within the Parks, design, as well as scale. The Hartley is situated within the retail center and active plaza at the north end of the site, while The Vale is adjacent to the bucolic Great Lawn and the historic Arts Park district. Both projects offer high-quality unit finishes and great building amenity packages, but with different interior design aesthetics. The Hartley has more of a nature-inspired, modern look, while The Vale has an artistic, contemporary vibe.
The Hartley is expected to include 58,000 square feet of retail space, whereas The Vale will have only 18,000 square feet. Moreover, units at The Hartley will be slightly larger. The other residential development, The Brooks, encompasses 89 condominiums with a different unit mix, unit sizing and amenity package.
What features set The Hartley apart from other multifamily projects?
Wiacek: The Hartley will have a Whole Foods store on the ground floor. At the same time, the project is designed to feature an indoor-outdoor connection, something that is also at the heart of the master plan. The ground-floor lobby connects through a staircase to the second-floor amenity space, which includes a double-height club room with views to the Parks plaza, and a coworking lounge and game lounge with access to two courtyards. These include a pool, an outdoor fitness area, grilling and dining areas, as well as a Zen garden. A gym and fitness studio space connects directly to the courtyards outdoor fitness zone. The penthouse level includes a more intimate party lounge and roof deck.
How will sustainability and technology be integrated in The Hartley?
Wiacek: Sustainability and energy efficiency are very important to The Parks project. The Hartley is designed to a LEED Silver standard and will include elements like a green roof, energy-efficient HVAC system, lighting and appliances. The site is an infill development, being constructed atop an existing ground-level parking garage, much of which will be reused.
The project is a short walk to the metro station as well as several bus routes, and multiple bike share stations will be added within The Parks. The technology part will include features such as smart thermostats, an intercom entry system and a package management system.
The Parks at Walter Reed will also include ambulatory care. Tell us a bit more about how your project is approaching resident health and wellness.
Wiacek: Access to health care will be found on the site, with a planned ambulatory care facility by Howard University. Childrens National Medical Center is constructing a pediatric research and innovation campus within the historic Walter Reed site, anchored by its Center for Genetic Medicine Research and Rare Disease Institute, as well as Johnson & Johnson JLABS @ Washington, D.C., Virginia Tech and The Biomedical Advanced Research and Development Authority. A clinic will house comprehensive primary-care services that will provide more convenient access to expert care for new and existing patients in northwest Washington, D.C.
We are fortunate to build on the legacy of the historic Walter Reed Army Medical Center, which was a place of healing for over a century. That legacy will be physically represented via the adaptive reuse of historic buildings and open spaces as we recognize that the built and natural environments have a tremendous impact on human health and wellness.
Plans for the development also include the creation of outdoor spaces, ranging from the historic Great Lawn and rose garden to a new playground and the retail-oriented central plaza. The site offers recreational opportunities for an active lifestyle, linking directly to Rock Creek Park and to healthy dining in the retail offerings. Whats also great about The Parks outdoor amenities is that they will be open to the wider community.
What can you share about financing the development?
Wiacek: Each project at The Parks at Walter Reed was separately financed. The Hartley project was financed with equity from a qualified opportunity fund through Bridge Investment Group and development partners Hines, Urban Atlantic and Triden Development Group. Santander Bank and EagleBank provided a construction loan.
What is the timeline for these projects?
Wiacek: Three projects are currently underway, including The Brooks, The Vale and The Hartley.The Brooks and The Vale are currently scheduled to open by the end of 2020 and early 2021, respectively.
What is the status of the other components of The Parks at Walter Reed?
Wiacek: We are in design now for two mixed-use, residential-over-retail projects. These projects will both be built above an existing parking garage that is being renovated under The Hartley contract. Our goal is to get these new projects underway by spring 2021, to align with The Hartley.
READ ALSO: Coronavirus Dents Multifamily Development
What impact do you expect The Parks at Walter Reed to have on D.C.s real estate market?
Wiacek: We think The Parks beautiful green spaces, unique historic buildings and walk-to retail opportunities will make it the Districts next mixed-use, live-work-play destination.
What about the impact on D.C.s multifamily sector in particular?
Wiacek: The District has a significant amount of multifamily in the pipeline. However, upper northwest D.C., where The Parks is located, has had limited new construction in the past decades. This project will provide an opportunity for new and existing residents to live and stay within this well-established area of northwest D.C., with great access to downtown and Maryland. The Parks offers an ideal blend of urban, walkable retail and amenities, with significant parks and open space.
Do you think the demand for luxury units in Washington, D.C., will shift in upcoming quarters, considering the economic slowdown caused by the pandemic?
Wiacek: COVID-19s resulting job losses may affect apartment demand in the D.C. area, though it is too early to forecast the exact impacts and duration. D.C.s economy has historically been bolstered by the stability of the federal government, which, in the wake of COVID-19, may add jobs that help offset job losses in the hospitality and service industries.
View post:
Washington, DCs The Parks at Walter Reed Makes Headway - Multi-Housing News
- Clemson professor Trudy Mackay elected to the National Academy of Medicine - Clemson News - October 22nd, 2024
- Research sheds new light on the behavior of KRAS gene in pancreatic and colorectal cancer - News-Medical.Net - October 22nd, 2024
- Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon - Nature.com - October 22nd, 2024
- Tailored Genetic Medicine: AAV Gene Therapy and mRNA Vaccines Redefine Healthcare's Future - Intelligent Living - October 22nd, 2024
- The Genetic Link to Parkinson's Disease - Hopkins Medicine - August 27th, 2022
- Epic Bio makes gene therapies by editing the epigenome - Labiotech.eu - August 27th, 2022
- Ovid turns to gene therapy startup to restock drug pipeline - BioPharma Dive - August 27th, 2022
- Whole-exome analysis of 177 pediatric patients with undiagnosed diseases | Scientific Reports - Nature.com - August 27th, 2022
- First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN (valoctocogene roxaparvovec), Approved by European Commission (EC) -... - August 27th, 2022
- Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases - BioSpace - August 27th, 2022
- ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines - Business Wire - August 27th, 2022
- ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene... - August 27th, 2022
- Genetic variants cause different reactions to psychedelic therapy - The Well : The Well - The Well - August 27th, 2022
- Personalized Medicine for Prostate Cancer: What It Is and How It Works - Healthline - August 27th, 2022
- Four radical new fertility treatments just a few years away from clinics - The Guardian - August 27th, 2022
- Why are Rats Used in Medical Research? - MedicalResearch.com - August 27th, 2022
- The Columns Stepping Stones in STEM Washington and Lee University - The Columns - August 27th, 2022
- Study points to new approach to clearing toxic waste from brain Washington University School of Medicine in St. Louis - Washington University School... - August 27th, 2022
- ALS Gene Therapy SynCav1 Found to Extend Survival in Mouse Model |... - ALS News Today - August 27th, 2022
- A New Kind of Chemo | The UCSB Current - The UCSB Current - August 27th, 2022
- Unraveling the mystery of who gets lung cancer and why - Genetic Literacy Project - June 16th, 2022
- How diet and the microbiome affect colorectal cancer - EurekAlert - June 16th, 2022
- Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear... - May 20th, 2022
- Money on the Move: SwanBio, Remix, Locus, Mirvie and More - BioSpace - May 20th, 2022
- DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Companies Bringing New Treatments to Patients - PR Newswire - May 20th, 2022
- Brain tumor growth may be halted with breast cancer drug - Medical News Today - May 20th, 2022
- LogicBio Therapeutics to Present at HC Wainwright Global Investment Conference - PR Newswire - May 20th, 2022
- Genascence Announces Data From Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, Presented at American Society of Gene... - May 20th, 2022
- Encoded Therapeutics Presents Nonclinical Data Showing Genomic Medicine Platform Yields Selective Expression to Optimize Gene Therapy Performance at... - May 20th, 2022
- California, Other States to Cover Rapid WGS of Newborns Under Medicaid, but Questions of Access Loom - GenomeWeb - May 20th, 2022
- Researchers Identify Role of 'Sonic the Hedgehog' Gene in Bone Repair - BioSpace - May 20th, 2022
- Targeting the Uneven Burden of Kidney Disease on Black Americans - The New York Times - May 20th, 2022
- ASC Therapeutics, U Mass Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine... - May 20th, 2022
- UC Davis Looks to Expand Genetic Breast Cancer Risk Education, Outreach for Hispanic Women - Precision Oncology News - May 20th, 2022
- Fly Researchers Find Another Layer to the Code of Life - Duke Today - May 20th, 2022
- CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Business... - May 20th, 2022
- Omicron BA.4 and BA.5: What to know about the new variants - Medical News Today - May 20th, 2022
- Krystal Biotech to Present Additional Data on B-VEC from the GEM-3 Phase 3 Study at the Society for Investigative Dermatology Annual Meeting -... - May 20th, 2022
- FDA approves Lilly's Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2... - May 20th, 2022
- Elucidating the developmental origin of life-sustaining adrenal glands | Penn Today - Penn Today - May 20th, 2022
- 5 questions facing gene therapy in 2022 - BioPharma Dive - January 17th, 2022
- In a First, Man Receives a Heart From a Genetically Altered Pig - The New York Times - January 17th, 2022
- Antibodies, Easy Single-Cell, Genomics for All: Notes from the JP Morgan Healthcare Conference - Bio-IT World - January 17th, 2022
- Using genetics to conserve wildlife - Pursuit - January 17th, 2022
- Genetics of sudden unexplained death in children - National Institutes of Health - January 17th, 2022
- Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance - Yahoo Finance - January 17th, 2022
- Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically... - January 17th, 2022
- How The mRNA Vaccines Were Made: Halting Progress and Happy Accidents - The New York Times - January 17th, 2022
- Press Registration Is Now Open for the 2022 ACMG Annual Clinical Genetics Meeting - PRNewswire - January 17th, 2022
- A Novel Mutation in the TRPM4 Gene | RRCC - Dove Medical Press - January 17th, 2022
- Biomarkers and Candidate Therapeutic Drugs in Heart Failure | IJGM - Dove Medical Press - January 17th, 2022
- Genetic counseling program helps patients take control of their health - Medical University of South Carolina - June 24th, 2021
- One-year-old baby in UAE receives imported genetic medicine to treat rare disease - Gulf News - June 24th, 2021
- Black and non-Hispanic White Women Found to Have No Differences in Genetic Risk for Breast Cancer - Cancer Network - June 24th, 2021
- What's in your genes | The Crusader Newspaper Group - The Chicago Cusader - June 24th, 2021
- Immusoft Announces Formation of Scientific Advisory Board - Business Wire - June 24th, 2021
- Arrowhead Presents Positive Interim Clinical Data on ARO-HSD Treatment in Patients with Suspected NASH at EASL International Liver Congress - Business... - June 24th, 2021
- Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole - GlobeNewswire - June 24th, 2021
- Despite the challenges of COVID-19, Yale-PCCSM section members continued their work on scientific papers - Yale School of Medicine - June 24th, 2021
- Veritas Intercontinental: Genetics makes it possible to identify cardiovascular genetic risk and prevent cardiac accidents such as those that have... - June 24th, 2021
- New Research Uncovers How Cancers with Common Gene Mutation Develop Resistance to Targeted Drugs - Newswise - June 24th, 2021
- Celebrate the Third Annual Medical Genetics Awareness Week April 13-16, 2021 - PRNewswire - February 14th, 2021
- How will WNY fare in the race between vaccines and coronavirus variants? - Buffalo News - February 14th, 2021
- Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences - GlobeNewswire - February 14th, 2021
- ASCO GU 2021: The Landscape of Genetic Alterations Using ctDNA-based Comprehensive Genomic Profiling in Pat... - UroToday - February 14th, 2021
- The Human Genome and the Making of a Skeptical Biologist - Scientific American - February 14th, 2021
- Breast Cancer Gene Mutations Found in 30% of All Women - Medscape - February 1st, 2021
- Mysterious untreatable fevers once devastated whole families. This doctor discovered what caused them - CNN - February 1st, 2021
- CCMB team identifies variants of genes that metabolise drugs - BusinessLine - February 1st, 2021
- NeuBase Therapeutics Announces Acquisition of Gene Modulating Technology from Vera Therapeutics - GlobeNewswire - February 1st, 2021
- Copy number variations linked to autism have diverse but overlapping effects - Spectrum - February 1st, 2021
- Genomes, Maps, And How They Affect You - IFLScience - February 1st, 2021
- SMART Study Finds 22q11.2 Microdeletion Prevalence Much Higher than Expected - PRNewswire - February 1st, 2021
- Are Phages Overlooked Mediators of Health and Disease? - The Scientist - February 1st, 2021
- When Your Chance for a Covid Shot Comes, Dont Worry About the Numbers - Kaiser Health News - February 1st, 2021
- Global CRISPR Gene Editing Market: Focus on Products, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and... - February 1st, 2021
- The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene MutationExtraordinary Results With Sotorasib - SurvivorNet - February 1st, 2021
- Genetic Testing: MedlinePlus - January 29th, 2021
- 21 Common Genetic Disorders: Types, Symptoms, Causes ... - January 29th, 2021
- Genetic Counseling Online Course - School of Medicine ... - January 29th, 2021